Search your stocks

Share

Profile

MONOPHARMAMono Pharmacare Ltd.

23.95(+0.00%)

1W: +1.91%

1M: -5.89%

1Y: -29.56%

Financials

Pros & Cons

POSITIVES

Revenue growth increased by 15% in the latest quarter compared to the previous year, reflecting strong demand in the manufacturing sector.
Gross margins improved to 28%, up from 25% last year, indicating better cost management and pricing strategies.
Operating profit rose by 20%, showing enhanced operational efficiency and effective use of resources.

NEGATIVES

Net profit margin declined by 2% this quarter, raising concerns about rising operational costs impacting profitability.
Debt levels increased by 10%, which may pose a risk to financial stability and could affect future investments.
Inventory turnover ratio decreased, suggesting potential issues in inventory management or overproduction.

Quarterly Results Data

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-